Paragard is a copper intrauterine device (IUD) used for long-term birth control. Manufactured by Teva Pharmaceuticals, it’s a non-hormonal option marketed as a safe and effective contraceptive method. However, numerous women have reported serious complications associated with the device, including device breakage during removal, leading to unexpected surgeries and potential long-term health issues.
Paragard lawsuits allege that Teva Pharmaceuticals failed to adequately warn patients and healthcare providers about the risks associated with the device, particularly the possibility of breakage during removal. It is claimed that the company knew or should have known about these risks but did not provide sufficient information or safety warnings. These lawsuits further assert that Teva downplayed the potential complications and overstated the ease of removal of the Paragard IUD.
By pursuing a Paragard lawsuit, you may be able to seek compensation for medical expenses, pain and suffering, lost wages, and other damages resulting from complications related to the device. Additionally, these legal actions aim to hold Teva Pharmaceuticals accountable for potentially putting profit over patient safety and to ensure that medical device manufacturers provide complete and accurate information about their products’ risks.
The first bellwether trial for the Paragard IUD multidistrict litigation (MDL) is set for December 1, 2025, with a second trial scheduled for February 2, 2026. This litigation addresses the issues faced by women whose Paragard intrauterine devices (IUDs) broke during removal, potentially causing severe complications. When a Paragard IUD breaks, it can require complex medical procedures to retrieve fragments. In more difficult cases, women may need hysteroscopies or even surgeries like laparoscopy if the pieces migrate outside the uterus, potentially affecting other organs and causing pain, infection, or scarring. Some cases lead to long-term complications, including infertility or bowel obstruction, due to the formation of adhesions.
Recently, 77 new cases were added to the MDL, bringing the total to 2,824, reflecting a resurgence in filings. As the bellwether trials approach, attention is on potential settlements. Expected settlement amounts will likely vary based on the severity of injuries, though defense attorneys contend that many cases do not involve permanent harm. Nevertheless, determining fair compensation for the suffering endured by affected women remains a core challenge as settlement discussions progress.
The Paragard lawsuit has reached a pivotal stage as the first bellwether trial is set to begin on October 28, 2024, after a six-month delay from its initial schedule in March. This bellwether trial, overseen by the U.S. District Court for the Northern District of Georgia, will play a crucial role in setting the direction for thousands of other cases in the multidistrict litigation (MDL), which now includes approximately 2,700 claims. Plaintiffs allege that the Paragard IUD’s design is defective, causing it to fracture upon removal and lead to severe injuries requiring further surgical intervention.
This October trial will test the core arguments from both sides, especially around evidence of Paragard’s tendency to break and the adequacy of warnings provided by the manufacturer, CooperSurgical. The outcome, while not binding for future cases, could influence settlement discussions and shape jury perceptions in subsequent trials. Furthermore, the bellwether outcomes may serve as a baseline for potential compensation frameworks or future settlements, particularly if Paragard cases continue to increase in volume, as seen with consistent filings throughout 2024.
The Paragard lawsuits have been consolidated into an MDL in the U.S. District Court for the Northern District of Georgia, where the number of pending cases continues to grow steadily. As of August 2024, there were 2,736 active cases, slightly down from 2,774 in July. The MDL is focusing on case-specific discovery and preparation for the first bellwether trials, which are representative cases selected to test the waters for future settlements and verdicts. The first bellwether trial is scheduled for October 28, 2024, although delays are common in such complex cases. In August 2024, several new lawsuits were filed directly into the MDL, often involving claims of severe complications during IUD removal. For example, a plaintiff in Georgia filed a new lawsuit after her Paragard IUD fractured during removal at a Planned Parenthood clinic in New York, causing significant pain and requiring further medical intervention.
Defense lawyers for Teva Pharmaceuticals and CooperSurgical, the manufacturers of Paragard, have filed motions to dismiss many cases based on the statute of limitations and the statute of repose. However, it is expected that few, if any, cases will be dismissed based on these grounds. The statute of repose, which sets a final deadline for filing lawsuits regardless of when the harm was discovered, could impact some older cases in certain jurisdictions.
There is speculation that the settlement amounts for Paragard lawsuits could vary widely, potentially ranging from $10,000 to over $250,000, depending on the severity of the injuries involved. This range is based on previous similar lawsuits and product liability cases. However, these amounts are not guaranteed, and actual settlements will depend on individual case outcomes and jury decisions. The court is also addressing discovery disputes and reviewing document production protocols to ensure fairness and transparency. This involves evaluating whether any relevant documents were incorrectly excluded from evidence, an important step for ensuring both sides have a fair chance to present their cases.
Overall, the Paragard MDL is progressing slowly, with both sides preparing for the initial trials that will set the tone for future settlements and litigation strategies. If you are interested in more detailed information or updates, you can check specific legal resources or consult with legal experts specializing in Paragard cases.
The Paragard IUD litigation remains active, with over 2,700 cases now consolidated under the multidistrict litigation (MDL) in the U.S. District Court for the Northern District of Georgia as August progresses. The lawsuits focus on allegations that the Paragard intrauterine device (IUD) can break during removal, leading to severe and sometimes irreversible complications. These complications include extreme pain, the necessity for additional surgeries to retrieve the broken pieces, potential infertility, and other long-term health issues.
Recent developments in the litigation have shown a consistent rise in the number of cases, although the rate of new filings has seen a slight deceleration compared to earlier months. Despite this, the growing number of plaintiffs highlights the widespread concerns over the safety of the Paragard IUD. Legal proceedings are advancing steadily, with significant activity around the discovery phase, where both sides are exchanging evidence and expert reports. Discussions have also focused on the leadership structure within the plaintiff committees, which play a crucial role in coordinating efforts across the many individual cases.
The court has been addressing various procedural motions, including those related to the admissibility of evidence, the scope of discovery, and the scheduling of bellwether trials. Bellwether trials are particularly important as they will serve as test cases to help predict outcomes for other lawsuits within the MDL. Legal experts following the case suggest that the outcomes of these bellwether trials could significantly impact settlement negotiations or verdicts in the remaining cases. In the meantime, law firms representing the plaintiffs continue to accept new clients, encouraging individuals who have experienced complications with the Paragard IUD to come forward. Potential plaintiffs who believe they have been harmed by the device may still can join the ongoing litigation, provided they meet specific legal criteria.
The legal battle surrounding Paragard is closely watched by both legal professionals and affected consumers, as it may set precedents for future product liability cases involving medical devices. We’re going to continue to press for more updates we learn more about the ongoing lawsuit and fight to make sure your voices are heard.
A new plaintiff, a woman from Southern California recently joined the Paragard IUD MDL lawsuit. According to the short-form complaint, the woman’s Paragard IUD fractured during removal in July 2022. The complaint alleges she required a second procedure in October 2022 to retrieve the broken pieces. This case highlights potential complications associated with Paragard IUD removal, a key focus of the ongoing litigation. The number of active cases in the MDL rose slightly from 2,690 on June 1, 2024, to 2,736 on July 1, 2024. This indicates a steady increase in the number of plaintiffs involved.
The update suggests a smaller MDL could be advantageous for plaintiffs due to several reasons. Fewer cases allow lawyers to concentrate on common legal arguments, potentially streamlining the process. A smaller caseload could lead to quicker settlements or trials when dealing with this case. With the size of cases growing smaller, it makes the possibility of settlements easier to gain, giving defendants the financial stability they need. As of July 10, 2024, there haven’t been any major settlements announced. The first bellwether trial is scheduled for October 28, 2024. The outcome could significantly impact future settlements.
These updates highlight the ongoing legal, financial, and procedural developments in the Paragard litigation, reflecting the dynamic nature of the case and the efforts to ensure a fair and efficient process for all parties involved.
In June 2024, significant updates emerged regarding the ongoing Paragard lawsuits. The number of cases has increased, with the multidistrict litigation (MDL) now including over 2,651 pending cases. These cases focus on the complications and injuries reported by users of the Paragard IUD, primarily concerning device breakage during removal which has led to severe health issues such as infections, internal injuries, and the need for additional surgeries.
The legal proceedings are actively progressing, with preparations for bellwether trials. These trials, scheduled to begin in 2025, will test the strengths of the cases and potentially influence future settlements. Changes in the Plaintiffs’ Leadership Committee have also been made to streamline and enhance the efficiency of the legal process, including reassignments and the addition of new members.
If you or someone you know has experienced complications with the Paragard IUD, you may be eligible to join the ongoing lawsuits. Legal consultations are available to discuss potential cases and help affected individuals understand their rights and options.
Our focus is on making sure that that you receive the attention you need and a clear path forward, all without any upfront costs. Our no-cost, no-obligation consultation outlines the steps we will take to fight for the justice and compensation you deserve.
DV Injury provides more than strong legal representation. We give you the support and reassurance you need during a challenging time in your life. Our goal is to ensure you’re not fighting the big corporations by yourself. We fight for you, and we don’t stop until justice is served.
You deserve the maximum amount for your distress and we do our level best to make sure you are properly compensated for pain and suffering, lost wages, medical expenses, and more. We’ve helped our clients recover hundreds of millions.
Contact us today for a free initial consultation.
We do not get paid unless you win.
Call or fill out the form below. We’ll contact you to schedule your free consulation.
